Breaking News Instant updates and real-time market news.

GSK

GlaxoSmithKline

$42.24

0.16 (0.38%)

05:36
10/11/19
10/11
05:36
10/11/19
05:36

GlaxoSmithKline upgraded to Buy from Hold at Cantor Fitzgerald

Cantor Fitzgerald analyst Brian White upgraded GlaxoSmithKline to Buy from Hold with a price target of 2,000 pence.

GSK GlaxoSmithKline
$42.24

0.16 (0.38%)

08/13/19
JPMS
08/13/19
INITIATION
JPMS
Neutral
GlaxoSmithKline reinstated with a Neutral at JPMorgan
JPMorgan analyst James Gordon reinstated coverage of GlaxoSmithKline with a Neutral rating and 1,700p price target. The analyst sees the stock near-term being Brexit and currency moves.
09/03/19
SOCG
09/03/19
UPGRADE
SOCG
Buy
GlaxoSmithKline upgraded to Buy from Sell at Societe Generale
09/03/19
SOCG
09/03/19
UPGRADE
SOCG
Buy
Societe Generale double upgrades GlaxoSmithKline to Buy
As previously reported, Societe Generale analyst Justin Smith upgraded GlaxoSmithKline to Buy from Sell in a research note titled 'An intriguing metamorphosis.' The analyst said he waited to upgrade the stock, despite liking "all the management and capital allocation changes" that new CEO Emma Walmsley has made in her first two years in charge, because he wanted to see "clear evidence of improving innovation" with GlaxoSmithKline's Pharma business. Smith now sees five high profile assets in Phase 3 that will release results in the next 3-4 years, giving improved pipeline visibility, and leaving the analyst forecasting "above-average sales growth from 2023."
09/04/19
COWN
09/04/19
NO CHANGE
Target $48
COWN
Outperform
Pfizer shares remain attractively valued, says Cowen
Cowen analyst Steve Scalia updated his Pfizer (PFE) model following Q2 results, the closing of the Glaxo (GSK) Consumer joint venture, and the announcement that its Upjohn business would be divested and combined with Mylan (MYL). The analyst lowered his estimates to reflect what is left at the company and despite his revision feels the shares remain attractively valued. Scalia reiterated his Outperform rating and $48 price target on Pfizer shares.

TODAY'S FREE FLY STORIES

KPLUF

K+S

$0.00

(0.00%)

05:34
10/14/19
10/14
05:34
10/14/19
05:34
Downgrade
K+S rating change  »

K+S downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVACF

Avance Gas

$0.00

(0.00%)

05:32
10/14/19
10/14
05:32
10/14/19
05:32
Upgrade
Avance Gas rating change  »

Avance Gas upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPG

Dorian LPG

$11.48

0.22 (1.95%)

05:30
10/14/19
10/14
05:30
10/14/19
05:30
Upgrade
Dorian LPG rating change  »

Dorian LPG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$43.58

(0.00%)

, PFE

Pfizer

$36.11

0.31 (0.87%)

05:25
10/14/19
10/14
05:25
10/14/19
05:25
Hot Stocks
AstraZeneca, Pfizer, Takeda Pharmaceutical enter collaboration with ImaginAb »

ImaginAb announced the…

AZN

AstraZeneca

$43.58

(0.00%)

PFE

Pfizer

$36.11

0.31 (0.87%)

TAK

Takeda Pharmaceutical

$17.29

0.21 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

GS

Goldman Sachs

$204.70

4.85 (2.43%)

, MS

Morgan Stanley

$41.94

0.92 (2.24%)

05:22
10/14/19
10/14
05:22
10/14/19
05:22
Recommendations
Goldman Sachs, Morgan Stanley, E-Trade analyst commentary  »

Hard for Goldman, Morgan…

GS

Goldman Sachs

$204.70

4.85 (2.43%)

MS

Morgan Stanley

$41.94

0.92 (2.24%)

ETFC

E-Trade

$39.49

0.53 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 17

    Oct

  • 17

    Oct

  • 27

    Oct

  • 10

    Nov

  • 12

    Nov

RHHBY

Roche

$0.00

(0.00%)

05:21
10/14/19
10/14
05:21
10/14/19
05:21
Hot Stocks
Genentech says Phase III PEMPHIX study met primary endpoint »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 06

    Nov

INCY

Incyte

$76.14

0.38 (0.50%)

05:16
10/14/19
10/14
05:16
10/14/19
05:16
Recommendations
Incyte analyst commentary  »

Incyte data enchances…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

MELI

MercadoLibre

$554.23

11.5 (2.12%)

05:11
10/14/19
10/14
05:11
10/14/19
05:11
Recommendations
MercadoLibre analyst commentary  »

MercadoLibre positioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 17

    Dec

PLNT

Planet Fitness

$58.63

0.94 (1.63%)

05:09
10/14/19
10/14
05:09
10/14/19
05:09
Upgrade
Planet Fitness rating change  »

Planet Fitness upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDOG

Datadog

$35.67

0.08 (0.22%)

05:06
10/14/19
10/14
05:06
10/14/19
05:06
Initiation
Datadog initiated  »

Datadog initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LMAT

LeMaitre

$31.29

-0.03 (-0.10%)

05:05
10/14/19
10/14
05:05
10/14/19
05:05
Upgrade
LeMaitre rating change  »

LeMaitre upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

IGMS

IGM Biosciences

$17.53

-0.125 (-0.71%)

05:03
10/14/19
10/14
05:03
10/14/19
05:03
Initiation
IGM Biosciences initiated  »

IGM Biosciences initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDOG

Datadog

$35.67

0.08 (0.22%)

05:01
10/14/19
10/14
05:01
10/14/19
05:01
Initiation
Datadog initiated  »

Datadog initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PING

Ping Identity

$16.47

0.45 (2.81%)

04:58
10/14/19
10/14
04:58
10/14/19
04:58
Initiation
Ping Identity initiated  »

Ping Identity initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NVST

Envista

$27.87

-1.2 (-4.13%)

04:57
10/14/19
10/14
04:57
10/14/19
04:57
Initiation
Envista initiated  »

Envista initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHK

Mohawk

$124.41

0.98 (0.79%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Downgrade
Mohawk rating change  »

Mohawk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

KBH

KB Home

$33.92

-0.15 (-0.44%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
SunTrust to hold a field trip »

Field Trip with KB Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTGT

TechTarget

$22.64

0.14 (0.62%)

, SKHCY

Sonic Healthcare

$0.00

(0.00%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Commvault to hold a conference »

Commvault GO 2019 will be…

TTGT

TechTarget

$22.64

0.14 (0.62%)

SKHCY

Sonic Healthcare

$0.00

(0.00%)

NTAP

NetApp

$51.50

1.74 (3.50%)

HPE

HP Enterprise

$14.35

0.24 (1.70%)

HLF

Herbalife Nutrition

$39.07

0.51 (1.32%)

FORR

Forrester

$32.43

0.61 (1.92%)

CSCO

Cisco

$46.52

0.38 (0.82%)

CVLT

Commvault

$45.51

0.695 (1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 23

    Oct

  • 29

    Oct

  • 29

    Oct

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 12

    Dec

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst…

ZLAB

Zai Lab

$32.38

0.01 (0.03%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Zai Lab participates in a conference call with JPMorgan »

SMid Biotechnology Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

SAN

Banco Santander

$4.10

0.155 (3.93%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Banco Santander management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Evercore REITs analyst to hold a luncheon »

REITs Analyst Sakwa holds…

WORK

Slack Technologies

$25.99

2.215 (9.32%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Slack Technologies management to meet with »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

MDLA

Medallia

$29.47

1.365 (4.86%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Medallia management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

CRNCY

Cairn Energy

$0.00

(0.00%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Cairn Energy management to meet with Bergenberg »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

  • 16

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.